Balance Sheet: Assets

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Elevance Health Inc., consolidated balance sheet: assets

US$ in millions

	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash and cash equivalents	8,288)	6,526)	7,387)	4,880)	5,741)
Fixed maturity securities	25,201)	29,614)	25,952)	26,267)	23,433)
Equity securities	1,192)	229)	953)	1,881)	1,559)
Premium receivables	8,011)	7,902)	7,083)	5,681)	5,279)
Self-funded receivables	5,044)	4,558)	4,663)	4,010)	2,849)
Other receivables	6,016)	5,405)	4,298)	3,749)	2,830)
Other current assets	4,700)	5,795)	5,281)	4,654)	4,060)
Assets held for sale	490)	—)	—)	—)	—)
Current assets	58,942)	60,029)	55,617)	51,122)	45,751)
Fixed maturity securities	1,035)	876)	752)	632)	562)
Other invested assets	9,749)	6,107)	5,685)	5,225)	4,285)
Long-term investments	10,784)	6,983)	6,437)	5,857)	4,847)
Property and equipment, net	4,652)	4,359)	4,316)	3,919)	3,483)
Goodwill	28,277)	25,317)	24,383)	24,228)	21,691)
Other intangible assets	12,094)	10,273)	10,315)	10,615)	9,405)
Other noncurrent assets	2,140)	1,967)	1,704)	1,719)	1,438)
Noncurrent assets	57,947)	48,899)	47,155)	46,338)	40,864)
Total assets	116,889)	108,928)	102,772)	97,460)	86,615)

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

An analysis of the annual financial data reveals several notable trends and shifts in asset composition over the observed five-year period.

Liquidity Position: Cash and cash equivalents exhibited fluctuations, declining from US$5,741 million in 2020 to US$4,880 million in 2021, then increasing significantly to US$7,387 million in 2022, followed by a slight decrease in 2023, and a substantial rise again to US$8,288 million by 2024. This pattern indicates active liquidity management with a strong ending position.
Investment Securities: Fixed maturity securities showed a general upward trend from US$23,433 million in 2020 to a peak of US$29,614 million in 2023, before declining to US$25,201 million in 2024, suggesting strategic repositioning in bond investments. Equity securities demonstrated volatility, rising initially to US$1,881 million in 2021, then dropping sharply to US$229 million in 2023, with recovery to US$1,192 million in 2024, indicating possible adjustments in equity holdings or market valuation impacts.
Receivables and Current Assets: Premium receivables steadily increased each year from US$5,279 million to US$8,011 million, reflecting growth in revenue-related receivables. Similarly, self-funded receivables and other receivables rose consistently, signaling expansion in account balances owed. Other current assets increased until 2023, then dropped notably in 2024. Overall, current assets grew from US$45,751 million in 2020 to US$60,029 million in 2023, with a slight decrease to US$58,942 million in 2024. The emergence of assets held for sale at US$490 million in 2024 suggests divestment activity.
Noncurrent Investments and Assets: Fixed maturity securities categorized under noncurrent assets increased steadily, while other invested assets and long-term investments both demonstrated robust growth, especially in 2024 where long-term investments jumped to US$10,784 million from US$6,983 million in 2023. This indicates a strategic emphasis on expanding long-term investment holdings.
Property, Equipment, and Intangible Assets: The net value of property and equipment showed consistent growth, signaling ongoing capital expenditures and asset maintenance. Goodwill increased progressively from US$21,691 million to US$28,277 million, indicating acquisitions or valuation adjustments. Other intangible assets remained relatively stable with minor fluctuations but rose notably in 2024 to US$12,094 million, reflecting possible additions or revaluations.
Total Assets: The total asset base expanded steadily from US$86,615 million in 2020 to US$116,889 million in 2024, showcasing overall growth and asset accumulation. This growth was driven by increases across cash, receivables, invested assets, and intangibles.

Assets: Selected Items

Download chart

Current Assets: Selected Items

Download chart

Elevance Health Inc. (NYSE:ELV)

Balance Sheet: Assets

Assets: Selected Items

Current Assets: Selected Items